舒芬太尼复合丙泊酚静脉麻醉对腹腔镜子宫肌瘤剔除术患者应用效果及对SAS评分影响.docVIP

舒芬太尼复合丙泊酚静脉麻醉对腹腔镜子宫肌瘤剔除术患者应用效果及对SAS评分影响 　　[摘要] 目的 研究舒芬太尼复合丙泊酚静脉麻醉对腹腔镜子宫肌瘤剔除术患者的应用效果及对SAS评分的影响。方法 方便选取2016年1月―2017年1月在该院接受腹腔镜子宫肌瘤剔除术的58例患者，随机分为观察组与对照组，其中对照组29例，采用舒芬太尼麻醉，观察组29例，采用舒芬太尼复合丙泊酚静脉麻醉。观察比较两组麻醉恢复时间，SAS评分的情况。结果 对比两组患者并发症发生率以及术中知晓率的差异，结果发现观察组并发症发生几率17.2%，术中知晓率0.0%，显著低于对照组41.4%和17.2%（P0.05）；对比两组患者SAS、SDS评分的差异，结果观察组SAS（39.43±5.41）分、SDS（44.31±3.45）分均显著低于对照组SAS（46.34±7.34）分、SDS（48.67±6.23）分（P0.05）。观察组患者麻醉效果较好，自主呼吸恢复时间、睁眼时间以及拔管时间均显著短于对照组（P0.05）。结论 舒芬太尼复合丙泊酚是目前较为良好的用于腹腔镜手术的麻醉配合药剂，值得在临床上推广使用。 　　[关键词] 舒芬太尼；丙泊酚；腹腔镜；子宫肌瘤 　　[中图分类号] R5 [文献标识码] A [文章编号] 1674-0742（2017）11（a）-0113-03 　　[Abstract] Objective To research the application effect of Intravenous anesthesia of sufentanil combined with propofol in patients with laparoscopic myomectomy and effect on SAS score. Methods 58 cases of patients with laparoscopic myomectomy treated in our hospital from January 2016 yo January 2017 were convenient selected and randomly divided into two groups with 29 cases in each， the control group adopted the sufentanil for anesthesia， while the observation group adopted the sufentanil combined with propofol for anesthesia， and the anesthesia recovery time， and SAS score of the two groups were observed and compared. Results The occurrence probability and postoperative awareness rate in the observation group were obviously lower than those in the control group（17.2%， 0.0% vs 41.4%， 17.2%），（P0.05）， and the SAS score and SDS score in the observation group were obviously lower than those in the control group，[（39.43±5.41）points，（44.31±3.45）points，vs（46.34±7.34）points，（48.67±6.23）points]，（P0.05）， and the anesthesia effect in the observation group was better， and the autonomous respiration recovery time， eye opening time and tube drawing time were obviously shorter than those in the control group（P0.05）. Conclusion The sufentanil combined with propofol is an anesthesia drug in the laparoscopic surgery， which is worth clinical promotion and application. 　　[Key words] Sufentanil； Propofol； Lapa